SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billkirn who wrote (2422)10/21/1997 10:46:00 AM
From: Tom DuBois  Read Replies (4) of 6136
 
Price action looks encouraging so far today. Here's a question for the group: I am long AGPH in my investment account but went out on a limb with Nov 47.5 and 50 calls in my speculative account. Probably should have cashed in at 56+ but got greedy. Now, does anyone see anything of substance on the near horizon that will propell AGPH toward John W's "70 by Nov"? Great earnings are old news. European approval seems to be a ways off still. Script data is still strong. etc. etc.

That's the dilemma...cash in at break even now or let the time value of the calls erode hoping for a pop or extended rally??? My decision to make, but any advice out there??

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext